Literature DB >> 24535727

Tea and coffee consumption and risk of esophageal cancer: the European prospective investigation into cancer and nutrition study.

Raul Zamora-Ros1, Leila Luján-Barroso, H Bas Bueno-de-Mesquita, Vincent K Dik, Heiner Boeing, Annika Steffen, Anne Tjønneland, Anja Olsen, Bodil Hammer Bech, Kim Overvad, Marie-Christine Boutron-Ruault, Antoine Racine, Guy Fagherazzi, Tilman Kuhn, Verena Katzke, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Rosario Tumino, Salvatore Panico, Paolo Vineis, Sara Grioni, Domenico Palli, Elisabete Weiderpass, Guri Skeie, José María Huerta, María-José Sánchez, Marcial Argüelles, Pilar Amiano, Eva Ardanaz, Lena Nilsson, Bengt Wallner, Björn Lindkvist, Peter Wallström, Petra H M Peeters, Timothy J Key, Kay-Thee Khaw, Nicholas J Wareham, Heinz Freisling, Magdalena Stepien, Pietro Ferrari, Marc J Gunter, Neil Murphy, Elio Riboli, Carlos A González.   

Abstract

Epidemiological data regarding tea and coffee consumption and risk of esophageal cancer (EC) is still inconclusive. We examined the association of tea and coffee consumption with EC risk among 442,143 men and women without cancer at baseline from 9 countries of the European Prospective Investigation into Cancer and Nutrition. Tea and coffee intakes were recorded using country-specific validated dietary questionnaires. Cox regression models were used to analyze the relationships between tea and coffee intake and EC risk. During a mean follow-up of 11.1 years, 339 participants developed EC, of which 142 were esophageal adenocarcinoma (EAC) and 174 were esophageal squamous cell carcinoma (ESCC). In the multivariable models, no significant associations between tea (mostly black tea), and coffee intake and risk of EC, EAC and ESCC were observed. In stratified analyses, among men coffee consumption was inversely related to ESCC (HR for comparison of extreme tertiles 0.42, 95% CI 0.20-0.88; p-trend=0.022), but not among women. In current smokers, a significant and inverse association was observed between ESCC risk and tea (HR 0.46, 95% CI 0.23-0.93; p-trend=0.053) and coffee consumption (HR 0.37, 95% CI 0.19-0.73; p-trend=0.011). However, no statistically significant findings were observed using the continuous variable (per 100 mL/d). These data did not show a significant association between tea and coffee consumption and EC, EAC and ESCC, although a decreased risk of ESCC among men and current smokers is suggested, but need to be confirmed in further prospective studies including more cases.
© 2014 UICC.

Entities:  

Keywords:  EPIC; coffee; esophageal cancer; smoking status; tea

Mesh:

Substances:

Year:  2014        PMID: 24535727     DOI: 10.1002/ijc.28789

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

Review 1.  Diet and upper gastrointestinal malignancies.

Authors:  Christian C Abnet; Douglas A Corley; Neal D Freedman; Farin Kamangar
Journal:  Gastroenterology       Date:  2015-02-11       Impact factor: 22.682

2.  Coffee or Tea, Hot or Cold, Are Not Associated With Risk of Barrett's Esophagus.

Authors:  Krishna C Sajja; Hashem B El-Serag; Aaron P Thrift
Journal:  Clin Gastroenterol Hepatol       Date:  2015-12-08       Impact factor: 11.382

3.  Hot Tea Consumption and Its Interactions With Alcohol and Tobacco Use on the Risk for Esophageal Cancer: A Population-Based Cohort Study.

Authors:  Canqing Yu; Haijing Tang; Yu Guo; Zheng Bian; Ling Yang; Yiping Chen; Aiyu Tang; Xue Zhou; Xu Yang; Junshi Chen; Zhengming Chen; Jun Lv; Liming Li
Journal:  Ann Intern Med       Date:  2018-02-06       Impact factor: 25.391

Review 4.  Coffee Consumption and Cancer Risk: An Assessment of the Health Implications Based on Recent Knowledge.

Authors:  Ernest K J Pauwels; Duccio Volterrani
Journal:  Med Princ Pract       Date:  2021-03-24       Impact factor: 1.927

5.  A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma.

Authors:  Farhad Islami; Hossein Poustchi; Akram Pourshams; Masoud Khoshnia; Abdolsamad Gharavi; Farin Kamangar; Sanford M Dawsey; Christian C Abnet; Paul Brennan; Mahdi Sheikh; Masoud Sotoudeh; Arash Nikmanesh; Shahin Merat; Arash Etemadi; Siavosh Nasseri Moghaddam; Paul D Pharoah; Bruce A Ponder; Nicholas E Day; Ahmedin Jemal; Paolo Boffetta; Reza Malekzadeh
Journal:  Int J Cancer       Date:  2019-03-20       Impact factor: 7.316

Review 6.  Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.

Authors:  Oliver John Kennedy; Paul Roderick; Ryan Buchanan; Jonathan Andrew Fallowfield; Peter Clive Hayes; Julie Parkes
Journal:  BMJ Open       Date:  2017-05-09       Impact factor: 2.692

Review 7.  An update of the WCRF/AICR systematic literature review and meta-analysis on dietary and anthropometric factors and esophageal cancer risk.

Authors:  S Vingeliene; D S M Chan; A R Vieira; E Polemiti; C Stevens; L Abar; D Navarro Rosenblatt; D C Greenwood; T Norat
Journal:  Ann Oncol       Date:  2017-10-01       Impact factor: 32.976

8.  Peanut consumption associated with a reduced risk of esophageal squamous cell carcinoma: A case-control study in a high-risk area in China.

Authors:  Yanjie Zhao; Lin Zhao; Zhiping Hu; Jiangping Wu; Jun Li; Chenxu Qu; Yongming He; Qingkun Song
Journal:  Thorac Cancer       Date:  2017-10-04       Impact factor: 3.500

9.  Coffee and cancer risk: A meta-analysis of prospective observational studies.

Authors:  Anqiang Wang; Shanshan Wang; Chengpei Zhu; Hanchun Huang; Liangcai Wu; Xueshuai Wan; Xiaobo Yang; Haohai Zhang; Ruoyu Miao; Lian He; Xinting Sang; Haitao Zhao
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

10.  Metabolites, Nutrients, and Lifestyle Factors in Relation to Coffee Consumption: An Environment-Wide Association Study.

Authors:  Mohamed A Elhadad; Nena Karavasiloglou; Wahyu Wulaningsih; Konstantinos K Tsilidis; Ioanna Tzoulaki; Chirag J Patel; Sabine Rohrmann
Journal:  Nutrients       Date:  2020-05-19       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.